848 results on '"A. de Groot"'
Search Results
2. Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain
3. Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab era
4. A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia
5. Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndrome
6. Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndrome
7. Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments
8. Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas
9. Neural Network Diagnoses the Antiphospholipid Syndrome without Interrupting Anticoagulant Therapy
10. Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival
11. Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen
12. The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis
13. Delayed normalisation of ADAMTS13 activity in acute Thrombotic Thrombocytopenic Purpura in the caplacizumab era
14. Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments
15. Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas
16. Histone Deacetylase Inhibition Restores Therapy Response in TP53mutated Acute Lymphoblastic Leukemia to Chemotherapy
17. Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival
18. Neural Network Diagnoses the Antiphospholipid Syndrome without Interrupting Anticoagulant Therapy
19. Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen
20. Dutch ALL11 Study: Improved Outcome for Acute Lymphoblastic Leukemia By Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for ETV6::RUNX1, Down Syndrome and Prednisone Poor Responders
21. Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts
22. Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B–associated thrombocytopenia
23. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL
24. Histone Deacetylase Inhibition Restores Therapy Response in TP53mutated Acute Lymphoblastic Leukemia to Chemotherapy
25. Dutch ALL11 Study: Improved Outcome for Acute Lymphoblastic Leukemia By Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for ETV6::RUNX1, Down Syndrome and Prednisone Poor Responders
26. The significance of autoantibodies against β2-glycoprotein I
27. F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
28. A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia
29. Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas
30. CD5 costimulation induces stable Th17 development by promoting IL-23R expression and sustained STAT3 activation
31. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor
32. β2-Glycoprotein I: a novel component of innate immunity
33. Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome
34. The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity
35. β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome
36. Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men
37. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
38. Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood
39. Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B
40. A Validated Risk Prediction Model for Bone Fragility in Children with Acute Lymphoblastic Leukemia
41. Impact of Allogeneic Hematopoietic Stem Cell Transplantation in First Complete Remission and Additional Cytogenetic Aberrations at Diagnosis on Prognosis in 1256 Pediatric Patients with KMT2A-Rearranged Acute Myeloid Leukemia: A Retrospective Study By the I-BFM-SG
42. Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men
43. Essential role of the disintegrin-like domain in ADAMTS13 function
44. A functional calcium-binding site in the metalloprotease domain of ADAMTS13
45. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients
46. Domain Specificity of Anti-Prothrombin Antibodies That Express Lupus Anticoagulant Activity
47. Spatial Technologies Reveal the Immune Landscape of Pediatric Acute Myeloid Leukemia
48. Implementation of Continuous Pegasparaginase Dosing without an Asparaginase-Free Interval Reduces Hypersensitivity in Children with Newly Diagnosed Acute Lymphoblastic Leukemia: Results of the DCOG ALL11 Pegasparaginase Randomization
49. Outcome of Intensively Treated Elderly AML Patients Reported to the Harmony Alliance Compares Well to Outcome of Control Patients of the Prospective Randomized HOVON 103 Study in Elderly AML
50. The Effect of Immunoglobulin Prophylaxis on Infectious Morbidity in Pediatric Patients with Acute Lymphoblastic Leukemia: Results of a Randomized Controlled Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.